诺思兰德: 承诺管理制度

Core Viewpoint - Beijing Northland Biotechnology Co., Ltd. has revised its Commitment Management System to enhance the regulation of commitments made by controlling shareholders, actual controllers, related parties, and other committers, ensuring the protection of minority investors' rights [1][2]. Chapter Summaries Chapter 1: General Principles - The revised system aims to strengthen the regulation of commitments made by the company and its related parties, in accordance with relevant laws and regulations [2]. Chapter 2: Commitment Management - Committers must provide clear performance deadlines for commitments related to stock issuance, refinancing, mergers, and other governance activities, ensuring compliance with industry policies [2][3]. - Committers are required to analyze the feasibility of commitments before making them and disclose any necessary approvals from regulatory authorities [2]. - Commitments must be specific, clear, and actionable, and the company is responsible for timely disclosure of these commitments [2][3]. Chapter 3: Rights and Obligations of Committers - Committers must adhere to their commitments and cannot change or waive them without valid reasons [4]. - Committers can change or waive commitments only under specific circumstances, such as changes in laws or natural disasters [4][5]. - The company must disclose reasons for any changes or waivers of commitments and seek shareholder approval for such changes [5]. Chapter 4: Supplementary Provisions - The system will be implemented after approval by the company's shareholders and will be interpreted by the board of directors [6].